Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04687215 · ClinicalTrials.gov registry record
Diabetic Neuropathy in Spinal Cord Stimulator Patients
A clinical trial of Diabetes Mellitus and Pain, Chronic, sponsored by University of Chicago.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT04687215: Recruiting study of Diabetes Mellitus and Pain, Chronic, sponsored by University of Chicago.
NCT04687215 is a study of Diabetes Mellitus and Pain, Chronic that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 25 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04687215, a study of Diabetes Mellitus and Pain, Chronic, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, improving micro-circulatory changes induced by Diabetes Mellitus (DM), improving macro-circulatory changes induced by DM and improving arterial stiffness of the vessels of the lower extremity.
Primary Outcome
Improve vascular changes (macroscopic: color, edema, ulceration, etc)
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-01-27 |
| Est. Completion | 2026-12-01 |
What NCT04687215 shows while recruiting
NCT04687215 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower).
The record links to 7 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.
NCT04687215 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04687215 about?
NCT04687215 is a clinical study titled "Diabetic Neuropathy in Spinal Cord Stimulator Patients". The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, imp...
What is the current status of trial NCT04687215?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2022-01-27. Estimated completion is 2026-12-01.
What conditions does trial NCT04687215 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Pain, Chronic, Vascular Diseases, Neuropathic Pain, Neuropathy.
Who is sponsoring clinical trial NCT04687215?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04687215 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04687215's enrollment target sits among peer trials
25 185th of 208 higher than 22 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI